One of the following is not a 5HT receptors on antagonist: (A) Ketanserine, (B) Lanreotide, (C) Methylsergide, (D) Tropisetron
Answer is B. Lanreotide is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide Refer kDT 6/e p166